-- 火曜日の米国株式市場は、半導体株の下落と中東情勢の緊迫化による原油価格の上昇を受け、主要株価指数は下落して取引を終えた。 * アーム・ホールディングス(ARM)、アプライド・マテリアルズ(AMAT)、ラムリサーチ(LRCX)、アリスタ・ネットワークス(ANET)、アドバンスト・マイクロ・デバイセズ(AMD)などがハイテク株の下落銘柄に含まれた。 * ロイター通信は、米当局者の話として、イランが中東戦争終結に向けて提示した最新の和平案は、ドナルド・トランプ大統領の支持を得られなかったと報じた。 * コンファレンス・ボードが発表した4月の消費者信頼感指数は、3月の改定値92.2から92.8に上昇した。ブルームバーグの調査では89が予想されていた。 * リッチモンド連銀が発表した4月の製造業景況指数は、3月の0から3に上昇し、ブルームバーグの調査では1が予想されていた。 * 5月限のWTI原油は3.51ドル上昇し、1バレル99.88ドルで取引を終えた。一方、国際指標である6月限のブレント原油は2.90ドル上昇し、111.13ドルで推移した。 * アレクサンドリア・リアル・エステート・エクイティーズ(ARE)の株価は、第1四半期の業績悪化を受けて11%下落し、S&P500種指数構成銘柄の中で最大の下げ幅となった。 * センテネ(CNC)の株価は、第1四半期の業績改善と2026年の業績見通し引き上げを受けて13%上昇し、S&P500種指数構成銘柄の中で最大の上げ幅となった。
Related Articles
Research Alert: Equity Residential Delivers Slight Ffo Beat And Revenue Miss In Q1 2026
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EQR delivered Q1 2026 FFO of $0.99, beating consensus by $0.02, though rental revenue of $780M slightly missed expectations. The company's blended lease rate of 1.5% remained flat Y/Y, with new lease rates declining 2.8% due to incentives offset by strong renewal rates of 4.7%. We maintain our Hold rating based on operating expense pressure suppressing cash NOI growth in 2026. Management guides for 2026 same-store revenue growth of 1.2%-3.2%, expense growth of 3.0%-4.0%, and cash NOI growth of 0.5%-2.5%, with strength expected in 2H 2026. EQR's coastal market strategy continues demonstrating value, with San Francisco leading at 6.5% revenue growth and New York at 4.6%, while expansion markets like Denver (-5.9%) and Atlanta (-2.0%) face new supply pressure. EQR has premium coastal markets where limited new supply enables pricing power, though higher operating costs remain a risk. The development pipeline totals $863M for 1,824 units when complete. Planned property acquisitions are $165M in 2026.
Rua Bioscience Notes 'Significant Contraction' in Australian Medical Cannabis Prescribing Volumes Amid Regulatory Review
Rua Bioscience (NZE:RUA) said the Australian market has experienced "significant contraction" in medical cannabis prescribing volumes amid a Therapeutic Goods Administration review of the safety of unapproved products, according to a Wednesday filing with the New Zealand bourse.However, medicinal cannabis is showing "strong signs of maturity and growth" in international markets, especially in Europe, in the face of recent international developments and discourse of a global economic slowdown, Rua added.The company recently established RUA genetics in Canada, the second-largest cannabis market in the world after the US, adding to its presence in Germany, Australia, New Zealand, Czechia, and the UK, per the filing.In Australia, the company expects a market reset after the regulatory review is complete, and is working to establish its products in new clinic chains.Elsewhere, Rua plans to bring several products to the New Zealand market in the coming months, and is also working on product launches in Czechia scheduled for May. Additionally, the company is looking to expand in the UK with plans to incorporate its genetics through new channels and clinic chains.In Germany, the company believes there is strong demand for consistent and reliable suppliers as significant regulatory changes seem unlikely following a review during which distributors reduced stock and scaled back imports. The German market remains competitive and continues to show strong signs of growth, Rua said.
Market Chatter: Nvidia-Linked Data Center Raises $4.6 Billion From Junk Bond Sale
A Nevada data center project tied to Nvidia (NVDA) has raised $4.59 billion through a junk-bond sale, underscoring a rise in deals for AI infrastructure funding, Bloomberg reported on Tuesday, citing a person familiar with the matter.The deal, backed by Tract Capital Management and Fleet Data Centers, priced five-year notes at a 6.74% yield, the report said.The project, a 200-megawatt facility in Nevada, is expected to be leased to Nvidia.The deal was priced during broader volatility in data center-linked stocks and bonds, as concerns grow over whether the rapid expansion in AI-related spending will deliver expected returns, Bloomberg said.Nvidia did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)